The 6-month treatment for multiple sclerosis (MS) can refer to the administration schedule of certain medications, such as OCREVUS.
OCREVUS is an FDA-approved medication for relapsing or primary progressive forms of MS. It is administered once every six months via intravenous (IV) infusion. Therefore, a 6-month MS treatment could refer to receiving an OCREVUS infusion every six months.
